Odd Lots cover image

Here Comes the Booming Chinese Biotech Sector

Odd Lots

00:00

Battlegrounds of Biotech: U.S. vs. China

This chapter explores the competitive dynamics between the U.S. and Chinese pharmaceutical industries, particularly in cancer treatment. It examines the landscape of biotech firms in China and the implications for American investors and companies facing increased competition and innovation challenges.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app